Saira A. Jan, MS, PharmD

Articles by Saira A. Jan, MS, PharmD

Adherence to Osteoporosis Medications After Patient and Physician Brief Education: Post Hoc Analysis of a Randomized Controlled Trial

ByAimee Der-Huey Shu, MD,Margaret R. Stedman, MPH,Jennifer M. Polinski, MPH, MS,Saira A. Jan, MS, PharmD,Minal Patel, MD, MPH,Colleen Truppo, RN, MBA,Laura Breiner, RN, BSN,Ya-ting Chen, PhD,Thomas W. Weiss, DrPH,Daniel H. Solomon, MD, MPH

July 7th 2009

Post hoc analysis of a randomized controlled trial found that a 1-session educational intervention targeted at patients and primary care physicians did not improve osteoporosis medication adherence.

Measuring Concurrent Adherence to Multiple Related Medications

ByNiteesh K. Choudhry, MD, PhD,William H. Shrank, MD, MSHS,Raisa L. Levin, MS,Joy L. Lee, BA,Saira A. Jan, MS, PharmD,M. Alan Brookhart, PhD,Daniel H. Solomon, MD, MPH

July 7th 2009

This study compares the performance of several definitions of concurrent adherence to related medications.

A Cost/Efficacy Analysis of Oral Antifungals Indicated for the Treatment of Onychomycosis: Griseofulvin, Itraconazole, and Terbinafine

ByJames T. Angello, RPh,Robert M. Poytovich, PharmD,Saira A. Jan, MS, PharmD

March 1st 1997

Saira A. Jan, MS, PharmD

Articles by Saira A. Jan, MS, PharmD

Adherence to Osteoporosis Medications After Patient and Physician Brief Education: Post Hoc Analysis of a Randomized Controlled Trial

Measuring Concurrent Adherence to Multiple Related Medications

A Cost/Efficacy Analysis of Oral Antifungals Indicated for the Treatment of Onychomycosis: Griseofulvin, Itraconazole, and Terbinafine

Latest Updated Articles

Trending on AJMC

Small Workflow Changes Close Big Gaps in CKM Screening

Trump Announces Timeline for 100% Generic Drug Tariffs Beginning in 2028, 200% in 2029

Fifth Death Confirmed in NYC Legionnaires' Outbreak

FDA Approves First Autoinjector for At-Home IV-Equivalent Diuresis

Pirtobrutinib Plus Venetoclax-Rituximab Cuts CLL Progression 45%